Max Healthcare to introduce 24×7 ward monitoring system

New Delhi, To bring Intensive Care Unit (ICU)-standard monitoring across general wards, Max Healthcare on Wednesday announced a partnership with US-based medical technology company Vios Medical to launch a continuous vital monitoring system built on a medical-grade Internet of Things (IoT) framework.

The technology provides continuous monitoring of vital signs such as oxygen saturation, heart rate, respiratory rate, electrocardiogram (ECG) and blood pressure in general wards, thereby enabling early detection and critical care facility even outside an ICU set-up.

The VIOS ward monitoring system comprises two connected sensors — chest and finger — which communicate wirelessly (via Bluetooth) with a bed-side tablet that maps all vital trends.

These, along with alarms (in case of adverse episodes/ change in trends), can be remotely viewed by nursing staff and clinicians at nursing stations and smartphones via web links.

This ensures that hospital staff can continuously monitor even the patients who are in rooms and ensure better care, Max Healthcare said in a statement.

“The psychosis/anxiety felt by patients under long term critical care has a strong impact on their recovery. With this technology solution, patients can experience 24×7 critical monitoring, even outside an ICU environment, helping them recover in the comfortable presence of loved ones,” said Sandeep Budhiraja, Clinical Director at Max Healthcare.

The technology also aids clinicians in making more effective treatment plans by providing vital trends and patterns, the statement added.

A successful pilot of the system, covering several specialties such as Cardiology, Pulmonology, Medicine and Neurology was conducted at Max Healthcare, Dehradun.

The system, which has the potential to reduce up to 30 per cent critical care costs as compared to ICU charges, will be launched soon across all network hospitals under Max Healthcare, the statement added.

  • Related Posts

    Zydus Lifesciences Q4FY26 net profit rises 9%

    Zydus board approved a buyback of up to Rs 1100 crore at Rs 1,150 per share, along with a 100 percent dividend for FY26. Zydus Lifesciences reported a rise in…

    Chemists strike on May 20: Reasons behind today’s all-India strike

    While major pharmacy chains and government medical outlets will remain operational, the strike highlights significant tensions within the industry that could impact access to medications nationwide. The All India Organisation…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Zydus Lifesciences Q4FY26 net profit rises 9%

    Zydus Lifesciences Q4FY26 net profit rises 9%

    Chemists strike on May 20: Reasons behind today’s all-India strike

    Chemists strike on May 20: Reasons behind today’s all-India strike

    AbbVie loses patent plea for Hep C drug

    AbbVie loses patent plea for Hep C drug

    GSK’s Calpol a well-known trademark: High Court

    GSK’s Calpol a well-known trademark: High Court

    3 arrested for allegedly posing as doctors using forged MBBS degrees

    3 arrested for allegedly posing as doctors using forged MBBS degrees

    Commissioner FDA reviews enforcement measures

    Commissioner FDA reviews enforcement measures